Abstract
During recent decades prognosis and survival in Hodgkin’s disease have improved strikingly. For all patients, the rate of cure is approximately 75% and for the majority, with limited disease (stage I-IIIA), it is nearly 90% (Zittoun et al. 1985). Improving the quality of life for the majority of patients has also been a basic aim in recent years (Hœrni et al. 1983; Eghbali and Hœrni-Simon 1984).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aaronson NK, Beckmann J (eds) (1987) The quality of life of cancer patients. Raven, New York
Anonymous (1987) Who should treat Hodgkin“s disease and where? Lancet I: 605
Behrendt H, Van Bunningen BNFM, Van Leeuwen EF (1987) Treatment of Hodgkin“s disease in children with or without radiotherapy. Cancer 59: 1870–1873
Bookman MA, Longo DL (1986) Concomitant illness in patients treated for Hodgkin“s disease. Cancer Treat Rev 13: 77–111
Brämswig JH, Heiermann E, Heimes U, Schlegel W, Nieschlag E, Schellong G (1987) Testicular function in boys treated for Hodgkin“s disease. Prospective evaluation in 68 boys of the DAL-HD-78 and DAL-HD-82 therapy study. Third International Conference on Malignant Lymphoma, Lugano (abstr p 25 )
Chauvergne J, Hcerni B, Hcerni-Simon G, Durand M, Lagarde C (1973) Chimiothérapie de la maladie de Hodgkin associant procarbazine, vinblastine, cyclophosphamide et méthylprednisolone. Analyse d“une série de 124 cures. Z Krebsforsch 80: 179–188
Combes PF, Desclaux B, Malissard L, Pons A (1977) Poids du diagnostic de maladie de Hodgkin sur la qualité de la vie des sujets qui en sont guéris. Bull Cancer (Paris) 64: 395–408
Cosset JM, Henry-Amar M, Ozanne F, Le Bourgeois JP (1984) Les péricardites radiques. Etudes des cas observés dans une série de 160 maladies de Hodgkin irradiées en mantelet à l“Institut Gustave-Roussy, de 1976 à 1980. J Eur Radiothérapie 5: 297–308
Eghbali H, Hcerni-Simon G (1984) Qualité de la vie et maladie de Hodgkin. In: Schraub S, Brugère J, Hcerni B (eds) Qualité de la vie et cancers. Progrès en cancérologie, 4. Doin, Paris, pp 283–290
Ferme C, Teillet F, d“Agay MF, Gisselbrecht C, Marty M, Boiron M (1984) Combined modality in Hodgkin“s disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging. Cancer 54: 2324–2329
Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D (1986) Psychosocial problems among survivors of Hodgkin“s disease. J Clin Oncol 4: 805–814
Gallez-Marchal D, Fayolle M, Henry-Amar M, Le Bourgeois JP, Rougier P, Cosset JM (1984) Radiation injuries of the gastrointestinal tract in Hodgkin“s disease: the role of exploratory laparotomy and fractionation. A study of 19 cases observed in a series of 134 patients treated at the Institut Gustave-Roussy from 1972 to 1982. Radiother Oncol 2: 93–99
Guinee VF, Guido JJ, Pfalzgraf KA et al. (1985) The incidence of herpes zoster in patients with Hodgkin“s disease. An analysis of prognostic factors. Cancer 56: 642–648
Henry-Amar M (1988) Quantitative risk of second cancer in patients in first complete remis-sion from early stages of Hodgkin“s disease. NCI Monogr 6: 65–72
Hcerni B (ed) (1982) L“information des personnes malades. SIMEP, Lyon-Villeurbanne
Hcerni B for Groupe Pierre-et-Marie-Curie (1985) Enquête psychosociale chez 28 adolescents traités pour une maladie de Hodgkin. Psychol Med 17: 1975–1976
Hcerni B, Hcerni-Simon G, Eghbali H, Richaud P (1983) Qualité de vie pendant et après association radio-chimiothérapique pour maladie de Hodgkin. Appréciation de 60 malades. Bull Cancer (Paris) 70: 284–288
Hcerni B, Zittoun R, Rojouan J et al. (1986a) Information des malades traités pour une maladie de Hodgkin. Liaisons avec la qualité de vie. Bull Cancer (Paris) 73: 305–310
Hcerni B, Zittoun R, Rojouan J et al. (1986 b) Retentissement psychosocial du traitement de la maladie de Hodgkin. Appréciation par questionnaire auprès de 150 malades. Bull Cancer (Paris) 73: 620–626
Hcerni B, Orgerie MB, Eghbali H et al. (1988) Nouvelle association d“epirubicine, bléomycine, vinblastine et prednisone (EBVPII) avant radiothérapie dans les stades localisés de maladie de Hodgkin. Essai de phase II chez 50 malades. Bull Cancer (Paris) 75: 789–794
Hcerni-Simon G, Zittoun R (1985) Coût thérapeutique et qualité de vie pendant et après le traitement d“une maladie de Hodgkin. In: Hcerni-Simon G, Gisselbrecht C (eds) Maladie de Hodgkin. Progrès en hématologie, 7. Doin, Paris, pp 179–191
Jacobs C, Ross RD, Walker IM, Stockdale FE (1983) Behavior of cancer patients: a randomized study of the effects of education and peer support groups. Am J Clin Oncol 6: 347–353
Lagarde P, Eghbali H, Bonichon F et al. (1988) Brief chemotherapy associated with extended field radiotherapy in Hodgkin“s disease. Long-term results in a series of 102 patients with clinical stages I-IIIA. Eur J Cancer Clin Oncol 24: 1191–1198
Pohjola-Sintonen S, Tötterman KJ, Salmo M, Siltanen P (1987) Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin“s disease. Cancer 60: 31–37
Santoro A, Bonfante V, Bonadonna G et al. (1981) Therapeutic and toxicologic effects of MOPP-ABVD combined with radiotherapy in Hodgkin“s disease. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton, New York, pp 85–91
Strull WM, Lo B, Charles G (1984) Do patients want to participate in medical decision making. JAMA 252: 2990–2994
Torti FM, Bristow MM, Lum BL et al. (1986) Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Cancer Res 46: 3722–3727
Wasserman AL, Thompson EI, Wilimas JA, Fairclough DL (1987) The psychological status of survivors of childhood/adolescent Hodgkin“s disease. Am J Dis Child 141: 626–631
Zittoun R (1985) Indications thérapeutiques et processus décisionnel dans la maladie de Hodgkin. In: Hcerni-Simon G, Gisselbrecht C (eds) Maladie de Hodgkin. Progrès en Hématologie, 7. Doin, Paris, pp 193–215
Zittoun R, Audebert A, Hcerni B et al. (1985) Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin“s disease. J Clin Oncol 3: 207–214
Zittoun R, Eghbali H, Audebert A et al. (1987) Association d“épirubicine, bleomycine, vinblastine et prednisone (EBVP) avant radiothérapie dans les stades localisés de la maladie de Hodgkin. Essai de phase II. Bull Cancer (Paris) 74: 151–157
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Hœrni, B., Eghbali, H. (1989). Quality of Life During and After Treatment of Hodgkin’s Disease. In: Diehl, V., Pfreundschuh, M., Loeffler, M. (eds) New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease. Recent Results in Cancer Research, vol 117. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83781-4_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-83781-4_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83783-8
Online ISBN: 978-3-642-83781-4
eBook Packages: Springer Book Archive